p53 expression in node-positive breast cancer patients: Results from the cancer and leukemia group B 9344 trial (159905) Academic Article uri icon

Overview

MeSH Major

  • Breast Neoplasms
  • Tumor Suppressor Protein p53

abstract

  • Nuclear staining of p53 by immunohistochemistry is associated with worse prognosis in node-positive patients treated with adjuvant doxorubicin-based chemotherapy but is not a useful predictor of benefit from doxorubicin dose escalation or the addition of paclitaxel.

publication date

  • August 2011

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3149770

Digital Object Identifier (DOI)

  • 10.1158/1078-0432.CCR-11-0484

PubMed ID

  • 21693655

Additional Document Info

start page

  • 5170

end page

  • 8

volume

  • 17

number

  • 15